DCIT CIRCLE-2(1)(1), AHMEDABAD, VEJALPUR vs. ERIS LIFESCIENCES LIMITED SHIVARTH AMBIT, BODAKDEV AHMEDABAD
In the result, for assessment year 2022-23, the appeal of the Department is partly allowed for statistical purposes
ITA 850/AHD/2025[2022-23]Status: DisposedITAT Ahmedabad09 Dec 2025AY 2022-23
Bench: Dr. Brr Kumar & Shri Siddhartha Nautiyal
For Appellant: Respondent by: Shri R P Rastogi, CIT-DR & Shri Abhijit, Sr. DRFor Respondent: Shri R P Rastogi, CIT-DR & Shri Abhijit, Sr. DR
Section 14ASection 36(1)(va)Section 37(1)Section 43BSection 80
10(38) (as then applicable) refers only to the amount of long-term capital gains computed in accordance with section 48, which mandates substitution of cost of acquisition with indexed cost of acquisition for long-
ITA Nos. 847to850/Ahd/2025 & 912to915/Ahd/2025
DCIT vs. Eris Lifesciences Ltd.
Eris Lifesciences Ltd. vs. DCIT
Asst. Years–2018-19 & 2020-21 to 2022-23
- 21–
term